MD Anderson Cancer Center

For nearly 80 years, MD Anderson has joined in the global fight to end cancer. Through its efforts in patient care, research, education and prevention, MD Anderson is changing the way in which cancer is treated and novel therapies are explored. Every clinic at MD Anderson has a team of physicians who are further specialized, each with a deep expertise in a form of cancer and treat more rare cancers in a single day than most see in a lifetime. Crucial scientific knowledge gained in the laboratory is rapidly translated into clinical care. MD Anderson’s clinical trials program is one of the largest of its kind, offering more than 1,400 clinical trials for common and rare cancers. In addition, MD Anderson ranked # 1 in cancer research funding through the National Institute of Health, spent over $900 M on research and over 190 patents awarded to its institution. Some of the world’s most recognized researchers and clinicians have been recognized in 2020 for their work, including 1 Nobel Laureate. ASCO also recognized three MD Anderson faculty with the highest honors. The three faculty members to be honored for their significant contributions to oncology are:Maura Gillison, M.D., Ph.D., professor of Thoracic/Head and Neck Medical Oncology, will receive the David A. Karnofsky Memorial Award and LectureBanu Arun, M.D., professor of Breast Medical Oncology, will receive the ASCO-American Cancer Society Award and LectureEmil J Freireich, M.D., who was a professor of Leukemia, will receive the Distinguished Achievement Award posthumouslyMD Anderson’s mission is to eliminate cancer and we will continue to set the standard in cancer prevention research and the translation of new knowledge into innovative, multidisciplinary care. The time is now, and we will stop at nothing to propel the pace of discovery and innovation in cancer science and care. Amidst a rapidly changing world, what will never change is our goal and our steadfast commitment to Making Cancer History®.... More Info Less Info